Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis
JiHoon Kang(Yale New Haven Hospital), Baek‐Yeol Ryoo(Asan Medical Center), Myung‐Hwan Kim(Korea Aerospace Research Institute), Dae Wook Hwang(Asan Medical Center), Sung Koo Lee(Ulsan College), Kyu‐pyo Kim(Ulsan College), Dong Wan Seo(Dankook University), Sang Hyun Shin(Ulsan College), Seung‐Mo Hong(Ulsan College), Song Cheol Kim(Ulsan College), Tae Jun Song, Changhoon Yoo(Ulsan College), Jae Hoon Lee(Ulsan College), Sang Soo Lee(Chungbuk National University Hospital), Jae Ho Jeong(Ulsan College), Inhwan Hwang(Ulsan College), Do Hyun Park(Massachusetts Institute of Technology), Heung-Moon Chang(Asan Medical Center), Ki Byung Song(Ulsan College)
Cited by 148
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
|Journal of Clinical Oncology|2019|1.8k
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
|Proceedings of the National Academy of Sciences|2017|577